Top funders for HPV and HPV-related cervical cancer R&D worldwide in 2018
In 2018, around 21 million U.S. dollars were spent by United States National Institutes of Health on research and development for Human papillomavirus (HPV) and HPV-related cervical cancer. This statistic shows the leading funders for HPV and HPV-related cervical cancer research and development (R&D) worldwide in 2018, in million U.S. dollars.